CIP
FLGT icon

Cornerstone Investment Partners’s Fulgent Genetics FLGT Stock Holding History

Cornerstone Investment Partners’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-9,450
Closed -$360K – 229
2022
Q3 		$360K Hold
9,450
– – 0.03% 78
2022
Q2 		$515K Hold
9,450
– – 0.03% 61
2022
Q1 		$590K Hold
9,450
– – 0.03% 65
2021
Q4 		$951K Hold
9,450
– – 0.05% 52
2021
Q3 		$850K Sell
9,450
-2,200
-19% -$200K 0.05% 56
2021
Q2 		$1.07M Hold
11,650
– – 0.06% 63
2021
Q1 		$1.13M Sell
11,650
-61
-0.5% -$6.3K 0.06% 58
2020
Q4 		$610K Hold
11,711
– – 0.04% 69
2020
Q3 		$469K Hold
11,711
– – 0.03% 74
2020
Q2 		$187K Sell
11,711
-1,510
-11% -$23.1K 0.01% 132
2020
Q1 		$142K Buy
+13,221
New +$184K 0.01% 129

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Cornerstone Investment Partners's FLGT Position: Q4 2022 in Review

Cornerstone Investment Partners sold out of Fulgent Genetics (FLGT) in Q4 2022, closing a stake of 9,450 shares — an estimated $360K sold.

Cornerstone Investment Partners first reported a position in FLGT in Q1 2020 and held it in 11 quarters. The position peaked at $1.13M in Q1 2021. 224 funds tracked by Wall St. Rank hold FLGT as of Q4 2022.

  • Cornerstone Investment Partners reported no remaining Fulgent Genetics position as of Q4 2022 after selling out during the quarter.
  • Cornerstone Investment Partners sold 9,450 Fulgent Genetics shares in Q4 2022, an estimated $360K.
  • Cornerstone Investment Partners first reported a position in Fulgent Genetics in Q1 2020 and held it in 11 quarters.
  • Cornerstone Investment Partners's Fulgent Genetics position peaked at $1.13M in Q1 2021.
  • 224 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2022.

Based on Cornerstone Investment Partners's 13F filing for Q4 2022, filed 1 Feb 2023.